| Mr Dennis Morgan Hydrick Jr, LPC | |
|
1465 Lakeland Dr, Jackson, MS 39216-4719 | |
| (601) 573-8548 | |
| (601) 968-0021 |
| Full Name | Mr Dennis Morgan Hydrick Jr |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 1465 Lakeland Dr, Jackson, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003982679 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Dennis Morgan Hydrick Jr, LPC 1465 Lakeland Dr, Jackson, MS 39216-4719 Ph: (601) 573-8548 | Mr Dennis Morgan Hydrick Jr, LPC 1465 Lakeland Dr, Jackson, MS 39216-4719 Ph: (601) 573-8548 |
News Archive
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland. The study also found that AMI is a more common cause of abdominal pain among the elderly than generally thought; however, it is difficult to diagnose before bowel damage develops.
A new report shows that while the overall rate of substance abuse treatment admissions among those aged 12 and older in the United States has remained nearly the same from 1999 to 2009, there has been a dramatic rise (430 percent) in the rate of treatment admissions for the abuse of prescription pain relievers during this period.
A new study by researchers at the University of Bern and published in the journal PLOS Medicine reports that while some people never experience any symptoms, most of those infected with the novel coronavirus do develop symptoms.
Using state-of-the-art robotic and x-ray crystallographic equipment, researchers at Saint Louis University have revealed for the first time the molecular structure of the zymogen, or inactive, form of a blood-clotting enzyme.
Tetraphase Pharmaceuticals, Inc., yesterday presented new clinical and preclinical data for its lead drug candidate, TP-434, which demonstrated the novel antibiotic as a once daily intravenous (I.V.) monotherapy capable of treating multidrug-resistant gram-negative pathogens while also having potency and broad spectrum coverage of other serious and multidrug resistant gram-positive pathogens.
› Verified 7 days ago
Mrs. Denease Inez Bishop, LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1855 Lakeland Dr, Suite P101, Jackson, MS 39216 Phone: 601-278-6790 | |
Robert Caleb Cauthen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1513 Lakeland Dr, Jackson, MS 39216 Phone: 769-777-1000 | |
Diane Lois Sanford, Counselor Medicare: Not Enrolled in Medicare Practice Location: 860 E River Pl Ste 100, Jackson, MS 39202 Phone: 769-251-5550 | |
Jamaal Murriel, MS,PCAT, PCMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1935 Lakeland Dr, Jackson, MS 39216 Phone: 601-718-2468 | |
Cheryl Marie Brown, Counselor Medicare: Not Enrolled in Medicare Practice Location: 341 Edgewood Terrace Dr, Jackson, MS 39206 Phone: 601-487-6344 Fax: 601-398-0289 | |
Ms. Delesia S Walker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 860 E River Pl Ste 100, Jackson, MS 39202 Phone: 769-251-5550 |